## Investigation of Choice for Organophosphate Poisoning ### Why RBC Acetylcholinesterase is the Gold Standard **Key Point:** Red blood cell (RBC) acetylcholinesterase activity is the MOST SPECIFIC and MOST SENSITIVE biomarker for organophosphate poisoning. It reflects the true target enzyme inhibition in the nervous system. ### Comparison of Cholinesterase Markers | Marker | Source | Specificity | Sensitivity | Clinical Use | |--------|--------|-------------|-------------|---------------| | **RBC acetylcholinesterase** | Red blood cells | Highest | Highest | Gold standard for diagnosis; correlates with CNS/neuromuscular effects | | Plasma pseudocholinesterase (butyrylcholinesterase) | Plasma | Moderate | Moderate | Reflects hepatic synthesis; less specific; variable genetic polymorphisms | | Serum cholinesterase | Serum | Low | Moderate | Non-specific; affected by liver disease, malnutrition, pregnancy | | Urine metabolites | Urine | Low | Low | Non-specific; delayed detection; not routinely available | ### Why RBC Acetylcholinesterase is Superior 1. **Organ-specific:** Acetylcholinesterase in RBCs is structurally identical to the enzyme at the neuromuscular junction and CNS synapses — the sites of toxicity. 2. **Irreversible inhibition:** Organophosphates phosphorylate and irreversibly inhibit acetylcholinesterase, causing accumulation of acetylcholine and cholinergic crisis. 3. **Diagnostic threshold:** A depression of >50% from baseline RBC acetylcholinesterase activity is diagnostic of organophosphate poisoning. 4. **Prognostic value:** The degree of depression correlates with clinical severity. **High-Yield:** RBC acetylcholinesterase activity recovers slowly (over weeks to months) after exposure, reflecting the time needed for new RBC synthesis. Plasma pseudocholinesterase recovers faster (days to weeks). ### Clinical Pearl In this acute presentation with classic cholinergic signs (pinpoint pupils, salivation, bronchospasm, fasciculations), RBC acetylcholinesterase should be measured immediately. A >50% reduction confirms the diagnosis and guides the intensity of atropine and pralidoxime therapy. **Warning:** Do NOT rely on plasma cholinesterase alone — it is less specific and can be abnormal in many conditions unrelated to organophosphate exposure (liver disease, malnutrition, genetic variants). [cite:KD Tripathi 8e Ch 12]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.